Patients are treated at the Dale and Deborah Smith Center for Alzheimer's Research and Treatment
Alzheimer's disease is a progressive neurological disease that attacks memory and other important brain functions. The Dale and Deborah Smith Center for Alzheimer's Research and Treatment at SIU Medicine provides focused treatment and therapy for the physical and emotional needs of patients and families suffering from this disease.
Request for new Alzheimers Drug
The FDA announced the approval for a drug called Aducanumab, to be given to patients. This is one of the first Alzheimer’s treatment designed to slow cognitive decline, and the first drug approved by the FDA to treat Alzheimer’s since 2003. The Dale and Deborah Smith Center for Research and Treatment will offer this to patients who meet the qualifications approved by the FDA for aducanumab. If you would like more information on when the drug will be available from SIU Medicine clinics, please complete the form below.
With a focus on continual improvement, our doctors take the time to research, study and innovate to provide the latest treatments for our patients.
Our care ranges from primary care physicians to specialists and sub-specialists who have advanced training. We're here for you when you need us.
Continually teaching the next generation of doctors, our physicians use the latest developments in procedures and technologies for our patients.